Renhe Pharmacy (000650.SZ): Moxifloxacin Hydrochloride Eye Drops Obtained Drug Registration Certificate.

Renhe Pharmacy (000650.SZ) announced that its subsidiary, Jiangxi Shining Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the moxifloxacin hydrochloride eye drops. Moxifloxacin hydrochloride eye drops are clinically used for the treatment of bacterial conjunctivitis caused by sensitive microorganisms (including Gram-positive bacteria, Gram-negative bacteria, chlamydia, etc.), and are classified as a second-class drug in the medical insurance catalog. The approval of the moxifloxacin hydrochloride eye drops as a chemical drug Class 4 marks that this product is considered to have passed the consistency evaluation of generic drugs.